205 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry

1784

BIONET
NT$65.900.5%-0.6%NT$3.1bn/aPE39.8xn/a1.1%Healthcare

4194

Holy Stone Healthcare
NT$20.45-2.4%-47.5%NT$3.0bn/aPS12.6xn/an/aPharmaceuticals & Biotech

4150

Unicon Optical
NT$19.95-1.7%94.6%NT$2.9bn/aPE14.1xn/an/aHealthcare

4106

Wellell
NT$28.000.9%-11.1%NT$2.8bn/aPE18.6xn/a3.0%Healthcare

6796

Medimaging Integrated Solution
NT$79.80-2.7%-16.7%NT$2.8bn/aPE37.3xn/a2.3%Healthcare

4168

GlycoNex Incorporation
NT$25.301.6%-17.6%NT$2.7bn/aPS1081.3xn/a0%Pharmaceuticals & Biotech

6539

DV Biomed
NT$45.95-0.3%-27.8%NT$2.7bn/aPE18xn/a10.9%Pharmaceuticals & Biotech

6955

Bonraybio
NT$157.50-1.3%n/aNT$2.7bn/an/an/an/aPharmaceuticals & Biotech

6815

Diamond Biotechnology
NT$95.201.6%55.3%NT$2.6bn/aPE56xn/a0.1%Healthcare

4130

Genovate Biotechnology
NT$23.90-0.8%-17.6%NT$2.6bn/aPE89.1xn/a0.6%Pharmaceuticals & Biotech

6677

Anxo Pharmaceutical
NT$46.05-1.1%-7.4%NT$2.6bn/aPE117.3xn/a0%Pharmaceuticals & Biotech

6857

Acer Medical
NT$168.00-0.6%111.3%NT$2.6bn/aPS93.2xn/an/aHealthcare

8432

TSH Biopharm
NT$65.601.9%46.1%NT$2.5bn/aPE27.3xn/a2.0%Pharmaceuticals & Biotech

4724

Meribank Biotech
NT$35.35-0.1%n/aNT$2.5bn/aPS10.7xn/an/aHealthcare

4116

BenQ Medical Technology
NT$55.400.2%-8.1%NT$2.5bn/aPE21.5xn/a3.6%Healthcare

6936

Vetnostrum Animal Health
NT$37.052.2%0.1%NT$2.5bn/an/an/an/aPharmaceuticals & Biotech

6637

Medical Imaging
NT$109.008.5%88.3%NT$2.3bn/aPE19.3xn/a2.8%Healthcare

6817

Winston Medical Supply
NT$125.00-7.1%42.0%NT$2.3bn/aPE14.5xn/a5.3%Pharmaceuticals & Biotech

6564

Enimmune
NT$34.55-5.2%-30.9%NT$2.3bn/aPS52.3xn/an/aPharmaceuticals & Biotech

6575

SyneuRx International (Taiwan)
NT$17.200%-69.6%NT$2.1bn/aPB7.7xn/an/aPharmaceuticals & Biotech

1295

Synbio Tech
NT$71.001.4%n/aNT$2.2bn/an/an/an/aPharmaceuticals & Biotech

6808

3D Global Biotech
NT$32.401.3%12.1%NT$2.2bn/aPS104.9xn/an/aPharmaceuticals & Biotech

6879

TCI GENE
NT$79.001.3%-36.0%NT$2.1bn/aPE179.1xn/a2.5%Healthcare

6918

Aplus Biotechnology
NT$68.50-1.9%59.7%NT$2.1bn/an/an/an/aHealthcare
Page 5 of 9
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.